Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
19.65
+0.57 (2.99%)
At close: May 15, 2025, 4:00 PM
19.60
-0.05 (-0.25%)
After-hours: May 15, 2025, 4:10 PM EDT
Genmab Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Genmab stock ranges from a low of $27 to a high of $48. The average analyst price target of $39.17 forecasts a 99.34% increase in the stock price over the next year.
Price Target: $39.17 (+99.34%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 9, 2025.
Analyst Ratings
The average analyst rating for Genmab stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 3 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 → $37 | Strong Buy | Reiterates | $50 → $37 | +88.30% | Apr 9, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +129.01% | Mar 11, 2025 |
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Mar 11, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $27 | Hold → Buy | Upgrades | $27 | +37.40% | Feb 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +154.45% | Jan 23, 2025 |
Financial Forecast
Revenue This Year
25.33B
from 21.53B
Increased by 17.69%
Revenue Next Year
29.09B
from 25.33B
Increased by 14.81%
EPS This Year
106.15
from 121.36
Decreased by -12.53%
EPS Next Year
127.16
from 106.15
Increased by 19.79%
Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.2B | 32.3B | 37.9B | ||
| Avg | 25.3B | 29.1B | 33.1B | ||
| Low | 22.6B | 26.0B | 28.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.1% | 27.5% | 30.4% | ||
| Avg | 17.7% | 14.8% | 13.8% | ||
| Low | 4.8% | 2.6% | -3.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 139.40 | 154.12 | 194.49 | ||
| Avg | 106.15 | 127.16 | 156.10 | ||
| Low | 81.78 | 94.71 | 114.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.9% | 45.2% | 52.9% | ||
| Avg | -12.5% | 19.8% | 22.8% | ||
| Low | -32.6% | -10.8% | -9.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.